Category: Support
The Game-Changing Care Model That’s Reducing IBD ER Visits by 22%
New research shows nurse practitioner-led IBD clinics are reducing emergency room visits by 22% and hospitalizations by 52%. This game-changing care model offers hope for more proactive, accessible IBD management that keeps patients stable and out of crisis.
New Crohn’s Drug Shows Promise in Major Clinical Trial
Chugai Pharmaceutical announces promising Phase III results for crovalimab, a new Crohn’s disease treatment showing significant improvements in both symptom relief and intestinal healing. We analyze what this breakthrough could mean for the IBD community.
The Long Road to Diagnosis: Why Getting Crohn’s Answers Takes So Long
Many Crohn’s patients see multiple doctors before getting diagnosed, facing dismissal and misdiagnosis along the way. Understanding why this happens and how to advocate for yourself can help you navigate the healthcare system more effectively and find the answers you deserve.
Breakthrough Stem Cell Therapy Shows Promise for Perianal Fistulas
The STOMP2 clinical trial shows promising results for AU-101, a stem cell therapy using patients’ own cells to heal Crohn’s perianal fistulas. This breakthrough represents a fundamental shift from managing symptoms to promoting lasting tissue repair and healing.
Better IBD Treatments on the Horizon: What Growth Means for Patients
Market analysis shows unprecedented growth in IBD research and treatment development, with new biologics, personalized medicine, and digital health platforms on the horizon. Here’s what this expansion means for patients and families managing Crohn’s disease and ulcerative colitis.
New UC Research Tackles Bowel Urgency – The Symptom That Controls Your Life
New clinical trial data shows promising improvements in bowel urgency for ulcerative colitis patients, addressing the symptom that often controls daily life more than any other UC symptom.
New UC Treatment Shows Promise in Just 3 Days
New clinical trial data shows OMVOH, an FDA-approved UC treatment, can start improving symptoms in just three days while maintaining benefits for a full year. This rapid-acting approach could change how we experience UC treatment, offering hope for faster relief and long-term stability.
Could This Overlooked Gut Bacteria Be a Game-Changer for IBD?
New research identifies Ruminococcus torques, a gut bacterium that strengthens the intestinal barrier and may offer new hope for IBD management. This discovery could lead to more targeted, microbiome-based therapies for inflammatory bowel disease.
Tremfya Breakthrough: First At-Home UC Treatment Changes Everything
The European Commission has approved Tremfya as the first IL-23 inhibitor that can be self-administered at home for UC treatment. This groundbreaking approval could transform how patients manage moderate to severe ulcerative colitis by eliminating the need for hospital infusions.
The Mediterranean Diet for UC: Why This Matters for Your Journey
New research suggests the Mediterranean-Style Diet could help people with ulcerative colitis by focusing on anti-inflammatory foods and flexible eating patterns. This approach shifts from restriction to nourishment, offering hope for better symptom management.
